Psilocybin therapy in the treatment of methamphetamine and opioid use disorders
In the last year, three million people in the United States have struggled with opioid use disorder, and another 1.5 million people have dealt with methamphetamine misuse. The Psychedelics as Medicine Report revealed opioid use disorder alone costs the US economy US$227 billion a year.
In 2020, over 56,000 deaths involving synthetic opioids were recorded, largely due to the widespread use of fentanyl in the illicit drug supply. This equates to more American lives lost than in the entirety of the Vietnam War.
To discuss clinical trials into the treatment of opioid use disorder and methamphetamine misuse, PSYCH spoke with Professor Paul Hutson, a co-investigator for both psilocybin studies at University of Wisconsin–Madison.READ MORE